Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Tsatalas
C
C
Department of Hematology, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. ktsatala@med.duth.gr
Margaritis
D
D
Kaloutsi
V
V
Martinis
G
G
Kotsianidis
I
I
Bourikas
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D016399:Lymphoma, T-Cell / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D014740:Vidarabine; C024352:fludarabine